The Science Behind Energy Supplements

Therapeutic dose: 18–65 mg/day elemental iron (when deficient); do NOT supplement without confirmed deficiency

See ranked Iron products→

• Cochrane review (2012) of 10 RCTs found iron supplementation significantly reduced fatigue in women with low ferritin (even without anemia). Fatigue improved by ~50% in iron-deficient non-anemic women.PubMed ↗
• 2014 meta-analysis confirmed iron supplementation significantly reduced subjective fatigue in women of reproductive age with low serum ferritin, with or without anemia.PubMed ↗
• Iron deficiency is the most common nutritional deficiency worldwide, affecting ~25% of the global population. Premenopausal women, athletes, and vegetarians are at highest risk.
• Critical safety note: iron supplementation in non-deficient individuals provides no energy benefit and can cause oxidative damage, GI distress, and iron overload. Ferritin testing before supplementation is essential. This is one supplement where 'more is not better' is literally dangerous.

Therapeutic dose: 75–400 mg/day (most benefits at 100–200 mg; do not exceed 400 mg/day)

See ranked Caffeine products→

• 2016 systematic review of 38 RCTs confirmed caffeine significantly improves alertness, attention, reaction time, and vigilance performance. Effects are dose-dependent and most reliable at 75–300 mg.PubMed ↗
• EFSA (European Food Safety Authority) concluded caffeine at 75 mg increases attention and alertness — one of the few health claims officially authorized for a supplement ingredient in the EU.
• Mechanism: adenosine receptor antagonist — blocks the sleep-promoting signal, increasing dopamine, norepinephrine, and acetylcholine activity. Half-life is 3–7 hours (varies with CYP1A2 genotype).
• Tolerance develops with chronic use, reducing the subjective energy boost while maintaining cognitive performance benefits. Withdrawal causes fatigue and headaches within 12–24 hours of cessation, lasting 2–9 days.

Therapeutic dose: 3–5 g/day (maintenance)

• Creatine's primary mechanism is phosphocreatine resynthesis — directly regenerating ATP, the cellular energy currency. ISSN Position Stand (2017) confirms creatine improves high-intensity exercise capacity via this energy pathway.PubMed ↗
• 2018 systematic review found creatine supplementation may reduce mental fatigue and improve cognitive performance during sleep deprivation and demanding mental tasks — an energy benefit beyond physical exercise.PubMed ↗
• Important distinction: creatine provides cellular energy (ATP) rather than stimulant-based perceived energy. Users will not 'feel' energized like with caffeine — the benefit is measurable in work output capacity and fatigue resistance.

Therapeutic dose: 100–300 mg/day (ubiquinol form preferred for absorption)

• Q-SYMBIO trial (2014, 420 patients with heart failure) found CoQ10 300 mg/day for 2 years significantly reduced major adverse cardiovascular events and all-cause mortality. Fatigue and dyspnea improved as secondary endpoints.PubMed ↗
• 2022 meta-analysis of 13 RCTs found CoQ10 supplementation significantly reduced fatigue severity across multiple conditions, including chronic fatigue, fibromyalgia, and statin-related fatigue.PubMed ↗
• CoQ10 is a required cofactor in the mitochondrial electron transport chain (complexes I–III). Without it, oxidative phosphorylation is impaired and ATP production drops. Endogenous synthesis declines with age — plasma levels decrease ~50% between ages 20 and 80.
• Statin drugs (HMG-CoA reductase inhibitors) reduce CoQ10 synthesis as a side effect, contributing to statin-associated muscle fatigue. Supplementation in statin users is supported by several RCTs showing reduced myalgia.

Therapeutic dose: 250–1,000 mcg/day (methylcobalamin or cyanocobalamin)

See ranked Vitamin B12 (Cobalamin) products→

• B12 deficiency causes megaloblastic anemia and neurological fatigue. Supplementation in deficient individuals rapidly reverses fatigue symptoms. Deficiency is common in vegans/vegetarians (~50% prevalence), older adults, and those on metformin or PPIs.
• 2015 systematic review found no evidence that B12 supplementation improves energy, cognitive function, or fatigue in individuals with normal B12 levels. The perception of B12 as an energy booster is a marketing myth in non-deficient populations.PubMed ↗
• Mechanism: B12 is a cofactor for methionine synthase and methylmalonyl-CoA mutase — required for DNA synthesis, red blood cell maturation, and mitochondrial fatty acid oxidation. Deficiency impairs all three pathways.
• Honest limitation: the massive energy drink and supplement marketing around B12 is largely unsupported by clinical evidence for the general population. Benefits are real and significant only when correcting a documented deficiency.

Therapeutic dose: 1,000–3,000 mg/day (as L-carnitine L-tartrate or acetyl-L-carnitine)

See ranked L-Carnitine products→

• 2018 meta-analysis of 11 RCTs found L-carnitine supplementation significantly increased maximal oxygen consumption (VO2max) and power output during exercise.PubMed ↗
• 2021 meta-analysis of 12 RCTs found L-carnitine significantly reduced fatigue in chronic fatigue syndrome, cancer-related fatigue, and aging-related fatigue populations.PubMed ↗
• Mechanism: L-carnitine transports long-chain fatty acids across the mitochondrial inner membrane for beta-oxidation. Without adequate carnitine, cells cannot efficiently burn fat for energy. Endogenous synthesis is usually sufficient in healthy adults eating meat.
• Nuance: benefits are more pronounced in older adults, vegetarians/vegans (carnitine is found almost exclusively in animal products), and patients with chronic fatigue. Healthy young omnivores are unlikely to be carnitine-deficient.

Therapeutic dose: 200–600 mg/day (standardized to 3% rosavins and 1% salidroside)

See ranked Rhodiola Rosea products→

• 2012 systematic review of 11 RCTs found Rhodiola rosea reduced physical fatigue and improved mental performance under stress conditions. Effects were most consistent for fatigue reduction during prolonged work or stress.PubMed ↗
• 2022 meta-analysis of 6 RCTs confirmed Rhodiola supplementation significantly reduced fatigue symptoms, with effects appearing within 1 week of supplementation in some trials.PubMed ↗
• 2012 RCT (101 subjects) found Rhodiola 200 mg twice daily for 4 weeks significantly improved stress-related fatigue, burnout symptoms, and concentration during stressful life periods.PubMed ↗
• Mechanism: adaptogenic effects likely mediated through HPA axis modulation, reducing cortisol response to stress. Also inhibits monoamine oxidase, increasing dopamine and serotonin availability. Unlike caffeine, does not cause jitteriness or withdrawal.

Therapeutic dose: 200–400 mg/day elemental magnesium

See ranked Magnesium products→

• Magnesium is required for ATP to be biologically active — ATP exists as Mg-ATP complexes. Every ATP-consuming reaction in the body (>300 enzymatic processes) requires magnesium. Deficiency directly impairs cellular energy production.
• 2012 RCT (46 older adults with marginal magnesium deficiency) found 12 weeks of magnesium supplementation significantly improved exercise performance (peak VO2) and reduced inflammatory markers.PubMed ↗
• Subclinical magnesium deficiency affects ~50% of US adults. Symptoms include fatigue, muscle weakness, and impaired exercise tolerance — often misattributed to other causes. Serum magnesium (standard blood test) is a poor marker; RBC magnesium is more accurate.
• Honest limitation: in magnesium-replete individuals, supplementation does not provide extra energy. The benefit is corrective, not enhancing.

Therapeutic dose: 1.3–10 mg/day

See ranked Vitamin B6 (Pyridoxine) products→

• B6 is a cofactor for >100 enzymatic reactions in amino acid metabolism and neurotransmitter synthesis (serotonin, dopamine, GABA). Severe deficiency causes fatigue and depression, but clinical deficiency is uncommon in developed countries.
• No RCTs demonstrate that B6 supplementation improves energy or reduces fatigue in non-deficient individuals. Its inclusion in energy supplements is based on its role in metabolism, not clinical evidence of energy enhancement.

Therapeutic dose: 400–800 mcg DFE/day

See ranked Folate (Vitamin B9) products→

• Folate deficiency causes megaloblastic anemia (identical to B12 deficiency presentation), leading to fatigue and weakness. Correcting deficiency resolves fatigue symptoms.
• Due to folic acid fortification of grain products (mandatory in the US since 1998), frank folate deficiency is now rare in the general population. Supplementation beyond RDA does not improve energy levels.

Therapeutic dose: 1.1–1.5 mg/day (RDA); therapeutic doses up to 100 mg in deficiency

See ranked Thiamine (Vitamin B1) products→

• Thiamine pyrophosphate is an essential cofactor for pyruvate dehydrogenase (glycolysis to TCA cycle) and alpha-ketoglutarate dehydrogenase (TCA cycle). Deficiency directly halts aerobic energy production.
• Deficiency (beriberi) causes severe fatigue, weakness, and neurological symptoms but is rare outside of chronic alcoholism, bariatric surgery patients, and severe malnutrition. No evidence supplementation enhances energy when thiamine-replete.

Therapeutic dose: 1.1–1.3 mg/day (RDA)

See ranked Riboflavin (Vitamin B2) products→

• Riboflavin is the precursor for FAD and FMN — cofactors essential for mitochondrial complexes I and II in the electron transport chain. Without riboflavin, oxidative phosphorylation is impaired.
• Deficiency is uncommon in developed countries (good dietary sources include dairy, eggs, meat). No clinical trials support riboflavin supplementation for energy in non-deficient adults.

Therapeutic dose: 14–16 mg/day NE (RDA); 500–2,000 mg for lipid-lowering (different indication)

See ranked Niacin (Vitamin B3) products→

• Niacin is the precursor for NAD+ and NADP+, central cofactors in cellular energy metabolism (glycolysis, TCA cycle, electron transport chain). Every energy-producing pathway requires NAD+.
• Pharmacological niacin doses (1–2 g/day) have established lipid-lowering effects but are associated with flushing, hepatotoxicity risk, and GI distress. This dose level is a drug, not a supplement, and is not recommended for energy.
• No clinical evidence that niacin supplementation at any dose improves subjective energy or fatigue in non-deficient adults. Pellagra (niacin deficiency) causes fatigue, but is virtually extinct in developed nations.

Therapeutic dose: 5 mg/day (AI); no established therapeutic dose for energy

See ranked Pantothenic Acid (Vitamin B5) products→

• Pantothenic acid is the precursor for coenzyme A (CoA) — required for fatty acid oxidation, the TCA cycle, and acetylcholine synthesis. Theoretically critical for energy metabolism.
• Deficiency is extremely rare ('pantothenic' comes from Greek 'pantos' meaning 'everywhere' — it's in almost all foods). There are zero RCTs testing pantothenic acid supplementation for energy or fatigue outcomes.

Therapeutic dose: 250–1,000 mg/day (from early human trials)

See ranked NMN (Nicotinamide Mononucleotide) products→

• Animal studies show NMN supplementation restores NAD+ levels in aged tissues, improving mitochondrial function, exercise capacity, and metabolic parameters. The longevity researcher David Sinclair popularized NMN, but human evidence lags far behind the animal data.
• 2022 RCT (48 recreationally trained adults) found NMN 600 mg/day for 6 weeks improved aerobic capacity during exercise training, suggesting potential energy/performance benefits.PubMed ↗
• Honest limitation: human RCTs are few, small, and short-term. Long-term safety in humans is unknown. The supplement is expensive and the evidence base does not yet justify the cost. NR (nicotinamide riboside) has slightly more human data but shares similar limitations.

Therapeutic dose: 250–1,000 mg/day

• 2018 RCT (NIAGEN trial, 120 adults aged 60–80) found NR 1,000 mg/day for 6 weeks successfully raised NAD+ levels by ~60% but did not significantly improve physical performance, mitochondrial function, or metabolic parameters.PubMed ↗
• 2019 RCT found NR supplementation in obese men increased NAD+ metabolites but did not improve insulin sensitivity, mitochondrial function, or body composition.PubMed ↗
• Key disconnect: NR reliably raises NAD+ levels (this is well-demonstrated), but raising NAD+ has not yet translated to clinical energy or performance benefits in human trials. The assumption that 'more NAD+ = more energy' remains unproven in humans.

Therapeutic dose: 1,000–3,000 mg/day

See ranked Taurine products→

• 2018 meta-analysis of 10 studies found taurine improved endurance exercise time to exhaustion, but the mechanism is unclear and most studies combined taurine with caffeine or other ingredients.PubMed ↗
• Taurine is included in virtually every energy drink, but its independent contribution to subjective energy is poorly studied. Most energy drink effects are attributable to caffeine and sugar, not taurine.
• Roles include bile acid conjugation, osmoregulation, membrane stabilization, and antioxidant activity. None of these directly translate to the kind of 'energy' consumers expect from an energy supplement.

Therapeutic dose: 250–500 mg/day (purified extract)

• 2019 pilot RCT (63 healthy overweight adults) found purified shilajit 250 mg twice daily for 8 weeks improved fatigue scores on a validated questionnaire, but the trial was small and industry-funded.PubMed ↗
• Contains fulvic acid and dibenzo-alpha-pyrones which may support mitochondrial electron transport in animal models. However, human bioavailability and mechanism are poorly characterized.
• Honest limitation: shilajit is a mineral pitch with highly variable composition depending on source and processing. Contamination with heavy metals is a documented safety concern. The evidence base consists of a few small, industry-funded trials. Traditional Ayurvedic use spans centuries, but traditional use alone does not constitute clinical evidence.